DashboardAll companies
Run this on your own research
Healthcare · Medical Devices

Boston Scientific Corporation

BSXNYSE$45.69−$0.32 (−0.70%)Market closed

Price Chart

Daily

Key facts

Market Cap
$67.17B
P/E
23.3x
P/B
2.79x
ROE
12.6%

Boston Scientific Corporation

Healthcare · Medical Devices · FY 2025

Boston Scientific Corporation, a leading global medical device company, is renowned for developing and supplying innovative health solutions. Its primary function is to design, manufacture, and market medical devices used in interventional medical specialties such as cardiology, peripheral interventions, cardiac rhythm management, endoscopy, urology, and neuromodulation. The company's product offerings significantly impact sectors like health care, particularly those focusing on minimally invasive treatments. Boston Scientific's products help improve the quality of patient care and reduce the need for major surgery, thus playing a crucial role in modern healthcare systems. Their devices contribute to procedures that are less invasive, more effective, and often more economic, supporting better patient outcomes and quicker recovery times. Founded in 1979 and headquartered in Marlborough, Massachusetts, Boston Scientific provides its products to healthcare providers and institutions worldwide. In the financial markets, Boston Scientific Corporation holds significant influence as a major player in the healthcare industry, contributing to advancements in medical technology and shaping the future of patient care through research and development. Its presence underscores the importance of innovation in medical devices and its role in enhancing healthcare delivery.

CEO
Mr. Michael F. Mahoney
Employees
53,000

Company Statistics

Valuation

P/E
23.3x
P/B
2.79x
P/S
3.37x
EV/EBITDA
14.5x
P/FCF
19.9x

Margins

Gross
69.0%
EBITDA
26.6%
Operating
19.8%
Pre-Tax
16.9%
Net
14.4%

Returns

ROA
7.0%
ROE
12.6%
ROIC
9.0%

Growth (CAGR)

Rev 3Yr
16.5%
Rev 5Yr
15.2%
Op Inc 3Yr
25.0%
Net Inc 3Yr
60.6%

Financial Health

Cash & Cash Equivalents
$1.97B
Net Debt
$17.24B
Debt/Equity
78.5%
Interest Cov
—

Profile

Revenue
$20.07B
Shares Out
—
Public markets · Korea, US, Japanalpha-lenz.com · Core by Treasurer
Boston Scientific Corporation (BSX) Stock Forecast 2026 $45.69 — Price, Financials & Analyst Targets | AlphaLenz